C4 Therapeutics, Inc.CCCCNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| 2025 | -5.78% |
| 2024 | -6.01% |
| 2023 | -0.11% |
| 2022 | 24.48% |
| 2021 | 20.68% |
| 2020 | 63.22% |
| 2019 | 68.09% |
| 2018 | 0.00% |